Management Team
MIMEDX has built a management team with highly experienced healthcare executives with track records of leading large healthcare organizations in generating growth, producing profitability, and increasing shareholder value. Our management team draws on guidance from an insightful board of directors and medical advisory board. Collectively, they are committed to achieving success, accomplishing our corporate goals and growing the company. The management team at MIMEDX includes:
Mr. Capper joined MIMEDX in January 2023 to lead the Company as Chief Executive Officer and Director. A highly experienced and accomplished healthcare executive, he brings nearly 30 years of experience in MedTech and Life Sciences leadership roles along with a track record of substantial value creation.
Peter M. Carlson was appointed Chief Financial Officer in March 2020, after joining MIMEDX in December 2019 as Executive Vice President of Finance.
Dr. Harper joined MIMEDX as Chief Technology Officer and Senior Vice President of Research and Product Development in June 2021. Most recently, he served as a Senior Medical Scientist in the Medical Solutions Division of 3M Health Care and Chief Technology Officer for 3M affiliate KCI, where he was responsible for all early-stage research, innovation and technology development and the study of mechanism of action of the company’s negative pressure wound care technology.
Mr. Hulse joined MIMEDX in December 2019, and brings to MIMEDX more than twenty years’ experience in large law firms and life sciences organizations, with significant legal, risk management, compliance and operational expertise.
Ms. Moller joined MIMEDX in August 2020 and brings significant sales leadership experience, clinical knowledge and understanding of the Advanced Wound Care marketplace to her role as Senior Vice President of Sales.
Dr. Robert B. Stein, M.D., Ph.D. joined MIMEDX in August 2020 as Executive Vice President, Research and Development. After completing his Bachelors of Science with honors, earning a double major in both biology and chemistry at Indiana University, Dr. Stein received his M.D. and Ph.D. in Physiology and Pharmacology and completed his internship, residency and Board Certification in Anatomic and Clinical Pathology, all at Duke University.
Mr. Smith joined MIMEDX in 2021 and currently serves as the Senior Vice President of Marketing & International. Prior to MIMEDX, Mr. Smith was the Chief Commercial Officer at Ascensus Surgical (formerly known as TransEnterix), a global provider of abdominal robotics and augmented reality systems.
A proven HR executive, Ms. Surdez brings more than 20 years of experience in Human Resources, having led talent acquisition, total rewards, succession and workforce planning, performance coaching, and organizational change management for several successful IPOs and large multinational biotech companies.
Ms. Whitlow joined MIMEDX in January 2023 as Chief Operating Officer. With a demonstrated background in operational leadership, Ms. Whitlow brings to her role more than 30 years of Life Sciences and Pharmaceutical experience.